Transient decrease in osteocalcin and markers of type 1 collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritis

W. F. Lems*, J. W.G. Jacobs, H. R. Van Den Brink, H. J.M. Van Rijn, J. W.J. Bijlsma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)

Abstract

The effect of corticosteroid pulse therapy on bone metabolism was studied in 10 patients with active RA. We measured alkaline phosphatase, osteocalcin and two recently introduced markers of collagen type 1 metabolism, reflecting synthesis (PICP) and degradation (ICTP).The day after the pulse therapy, there was a statistically significant (P<0.05) decrease in osteocalcin, PICP and ICTP from the value at start. Three weeks after pulse therapy, these values had returned to baseline.During pulse treatment there is a transient decrease in bone formation, as shown by the changes in osteocalcin and PICP. Because of the changes in ICTP, we conclude that bone resorption is transiently reduced as well, but whether these changes result from a direct or an indirect effect on bone is not clear. ICTP has to be investigated further as a (serum) marker of bone resorption.

Original languageEnglish
Pages (from-to)787-789
Number of pages3
JournalRheumatology
Volume32
Issue number9
DOIs
Publication statusPublished - 1 Sept 1993

Keywords

  • Bone metabolism
  • Corticosteroids
  • Osteocalcin
  • Rheumatoid arthritis

Fingerprint

Dive into the research topics of 'Transient decrease in osteocalcin and markers of type 1 collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this